LogicBio Therapeutics, Inc. Operating Lease Cost
LogicBio Therapeutics, Inc. reported Operating Lease Cost of $378.00 thousand for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2022-11-14
- LogicBio Therapeutics, Inc. operating lease, cost for the quarter ending 2022-09-30 was $378.00K, a 0.00% change year-over-year.
- LogicBio Therapeutics, Inc. operating lease, cost for the quarter ending 2022-06-30 was $378.00K, a 0.00% change year-over-year.
- LogicBio Therapeutics, Inc. operating lease, cost for the quarter ending 2022-03-31 was $378.00K, a 0.00% change year-over-year.
- LogicBio Therapeutics, Inc. operating lease, cost for the quarter ending 2021-12-31 was $378.00K, a 7.13% decline year-over-year.
- LogicBio Therapeutics, Inc. operating lease, cost for fiscal 2021 was $1.51M, a 8.97% decline from fiscal 2020.
- LogicBio Therapeutics, Inc. operating lease, cost for fiscal 2020 was $1.66M, a 37.50% increase from fiscal 2019.
- LogicBio Therapeutics, Inc. operating lease, cost for fiscal 2019 was $1.21M.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2022-09-30 | $378.00K 10-Q · filed 2022-11-14 | $756.00K derived: sum of 2 quarters · filed 2022-11-14 | $1.13M 10-Q · filed 2022-11-14 | $1.51M derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-06-30 | $378.00K 10-Q · filed 2022-08-15 | $756.00K 10-Q · filed 2022-08-15 | $1.13M derived: sum of 3 quarters · filed 2022-08-15 | $1.51M derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-03-31 | $378.00K 10-Q · filed 2022-05-16 | $756.00K derived: sum of 2 quarters · filed 2022-05-16 | $1.13M derived: sum of 3 quarters · filed 2022-11-14 | $1.51M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-12-31 | $378.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | $756.00K derived: sum of 2 quarters · filed 2022-11-14 | $1.13M derived: sum of 3 quarters · filed 2022-11-14 | $1.51M 10-K · filed 2022-03-04 |
| 2021-09-30 | $378.00K 10-Q · filed 2022-11-14 | $756.00K derived: sum of 2 quarters · filed 2022-11-14 | $1.13M 10-Q · filed 2022-11-14 | $1.54M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $378.00K 10-Q · filed 2022-08-15 | $756.00K 10-Q · filed 2022-08-15 | $1.16M derived: sum of 3 quarters · filed 2022-08-15 | $1.63M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $378.00K 10-Q · filed 2022-05-16 | $785.00K derived: sum of 2 quarters · filed 2022-05-16 | $1.25M derived: sum of 3 quarters · filed 2022-05-16 | $1.71M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $407.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | $872.00K derived: sum of 2 quarters · filed 2022-03-04 | $1.34M derived: sum of 3 quarters · filed 2022-03-04 | $1.66M 10-K · filed 2022-03-04 |
| 2020-09-30 | $465.00K 10-Q · filed 2021-11-15 | $929.00K derived: sum of 2 quarters · filed 2021-11-15 | $1.25M 10-Q · filed 2021-11-15 | $1.56M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $464.00K 10-Q · filed 2021-08-09 | $789.00K 10-Q · filed 2021-08-09 | $1.10M derived: sum of 3 quarters · filed 2021-08-09 | $1.41M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | $325.00K 10-Q · filed 2021-05-10 | $632.00K derived: sum of 2 quarters · filed 2021-05-10 | $944.00K derived: sum of 3 quarters · filed 2021-05-10 | $1.26M derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | $307.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $619.00K derived: sum of 2 quarters · filed 2021-03-15 | $934.00K derived: sum of 3 quarters · filed 2021-03-15 | $1.21M 10-K · filed 2021-03-15 |
| 2019-09-30 | $312.00K 10-Q · filed 2020-11-09 | $627.00K derived: sum of 2 quarters · filed 2020-11-09 | $901.00K 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $315.00K 10-Q · filed 2020-08-10 | $589.00K 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | $274.00K 10-Q · filed 2020-05-11 |